Abacavir and Quixin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Abacavir and Quixin together.
The phase IV clinical study analyzes what interactions people who take Abacavir and Quixin have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Abacavir and Quixin together, and have interactions are studied.
What is Abacavir?
Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,092 Abacavir users for its effectiveness, alternative drugs and more.
What is Quixin?
Quixin has active ingredients of levofloxacin. eHealthMe is studying from 53 Quixin users for its effectiveness, alternative drugs and more.
Number of Abacavir and Quixin reports submitted per year:
Common Abacavir and Quixin drug interactions by gender *:
female:
n/a
male:
- Cardiac failure
Common Abacavir and Quixin drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Cardiac failure
* Approximation only. Some reports may have incomplete information.
Do you take Abacavir and Quixin?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
- MITTAL V, ARCHANA D, GUPTA A, SRIVASTAV U, CHANDRA V, SAXENA A, AGRAWAL P, "Aphasia: a Rarest Complication with a Well Known Drug Levofloxacin", Medical Science, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Abacavir and Quixin:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Abacavir side effects:
- Fever: 655 reports
- Nausea and vomiting: 548 reports
- Diarrhea: 432 reports
- Fatigue (feeling of tiredness): 379 reports
Browse all side effects of Abacavir:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Abacavir interactions:
- Abacavir and Lamivudine: 2,153 reports
- Abacavir and Efavirenz: 1,694 reports
- Abacavir and Nevirapine: 1,302 reports
- Abacavir and Didanosine: 1,293 reports
- Abacavir and Stavudine: 1,163 reports
- Abacavir and Kaletra: 1,158 reports
- Abacavir and Ritonavir: 1,148 reports
- Abacavir and Norvir: 775 reports
- Abacavir and Zidovudine: 742 reports
- Abacavir and Tenofovir disoproxil fumarate: 735 reports
Browse all interactions between Abacavir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on abacavir sulfate and levofloxacin (the active ingredients of Abacavir and Quixin, respectively), and Abacavir and Quixin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Abacavir and Quixin.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Minirin and Hypertonic Bladder - 11 seconds ago
- Gentak and Losartan drug interaction - 15 seconds ago
- Tramadol Hydrochloride and Congestive Cardiomyopathy - 21 seconds ago
- Crohn'S Disease and Bile Duct Stenosis - 22 seconds ago
- Cyclosporine and Uterine Cyst - 23 seconds ago
- Myfortic and Confusional State - 28 seconds ago
- Myfortic and Nephropathy Toxic - 39 seconds ago
- Trusopt and Nephrogenic Anaemia - 42 seconds ago
- Multaq and Myasthenia Gravis Aggravated - 44 seconds ago
- Gilenya and Middle Ear Disorder - 46 seconds ago